Lincoln Pharma 32nd AGM: dividend and director reappointments approved
LINCOLN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.9 pts less than Nifty Microcap 250 and 1.0 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
32nd AGM held on Sep 30, 2026 via video conferencing with 80 members attending. All 5 resolutions passed with wide margins. Final dividend of Rs 1.80 per share (18%) for FY26 approved with 100% assent. Audited financial statements adopted. Two directors, Hashmukh Patel and Munjal Patel, reappointed via rotation. Cost auditor remuneration of Rs 2.5 lakh ratified. MD Mahendra Patel, who chaired in place of Kishor Shah, highlighted 4 new domestic divisions, expanded Khatraj plant, operational Mehsana plant and new API facility. Exports contribute 62 percent, domestic 38 percent of sales. Wind and solar projects meet 100 percent of energy needs.
Routine AGM. Dividend of Rs 1.80 per share confirmed. New divisions and API facility signal growth focus. All resolutions passed with wide margins.